Main Session
Sep
30
SH 07 - Head and Neck Cancer - Science Highlights
255 - The HYPCON Trial 2: A Phase II Randomized Study Evaluating Hypofractionated vs. Conventional Adjuvant Concurrent Chemoradiation in Head and Neck Malignancies
Presenter(s)
Aarcha Ramadas, MBBS - AIIMS New Delhi, New Delhi, Delhi